Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Probi AB has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Prosecution is currently limited to 1 distinct examiner and 1 distinct art unit. This indicates a very specific focus for the company's active patent applications, likely centered on a single probiotic or biotechnological innovation. The use of 1 distinct examiner suggests that the company's current workload is manageable through a single point of contact at the patent office. This concentration allows for a consistent prosecution strategy within the life sciences sector.
EDWARDS, JESSICA FAYE is the busiest examiner, overseeing 1 busiest examiner pending action. This single action constitutes the entire pending workload for Probi AB. The examiner's review within this 1 art unit is the sole factor currently influencing the company's patent prosecution outcomes. Practitioners should prioritize understanding the specific examination style of this 1 examiner to effectively resolve the 1 pending action. The company's immediate patent success in the Biotechnology & Pharmaceuticals sector depends entirely on this single interaction. The resolution of this case will define the company's current standing in the biotechnology field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, JESSICA FAYE | 1 | 39.1% | +46.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17616968 | LACTOBACILLUS COMPOSITIONS AND USES THEREOF | EDWARDS, JESSICA FAYE | 1d overdue |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17616968 | LACTOBACILLUS COMPOSITIONS AND USES THEREOF | EDWARDS, JESSICA FAYE | 1657 | §103 | Final Rejection | 1d overdue | Pending | Dec 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial